Monitoring blood glucose concentration aids in proper management of diabetes.
SEATTLE, WASHINGTON, UNITED STATES, December 13, 2021 /EINPresswire.com/ — Monitoring blood glucose concentration aids in proper management of diabetes. There are two ways of monitoring: invasive and non-invasive blood glucose monitoring. Several research groups have been working feverishly to develop medically useful wearable monitors for non-invasive continuous glucose monitoring, yet, to date, there are very few scientifically proven non-invasive glucose monitor products on the non-invasive blood glucose monitoring devices market.
Click Here To Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/54
Major players operating in the global non-invasive diabetes therapy market are focused on launching new products to expand their product portfolio. For instance, in April 2020, DexCom, Inc. launched a new patient assistance program that offers two 90-day supply shipments of Dexcom continuous glucose monitoring (CGM) system supplies and reduces customer cost to US$ 45 per 90-day supply shipment, in order to aid current U.S. customers who have lost insurance due to the COVID-19 pandemic.
Global Non-Invasive Diabetes Therapy Market: Drivers
The global non-invasive diabetes therapy market growth is driven by high prevalence of diabetes worldwide. For instance, according to the study, ‘Global Prevalence of Type 2 Diabetes over the Next Ten Years (2018-2028)’, published by the American Diabetes Association, 500 million people worldwide suffered from type 2 diabetes in 2018.
Global Non-Invasive Diabetes Therapy Market: Opportunities
R&D in non-invasive alternatives is expected to offer lucrative growth opportunities for players in the global non-invasive diabetes therapy market. For instance, in August 2019, a team of researchers tested the efficacy of a new hormone injection that could aid weight loss in obese patients with diabetes. This could potentially serve as a non-invasive alternative for gastric bypass surgery.
Similarly, in July 2019, researchers from the University of Michigan announced an upcoming clinical trial that involves a new non-invasive, endoscopic weight-loss procedure, EndoBarrier developed by GI Dynamics Inc. The clinical trial of EndoBarrier will include individuals with type 2 diabetes and obesity.
Asia Pacific is expected to witness significant growth in the global non-invasive diabetes therapy market, owing to high prevalence of diabetes in the region. For instance, according to the National Diabetes and Diabetic Retinopathy Survey report published in October 2019, the prevalence of diabetes in India was 11.8% during 2015-2019 and the prevalence of known diabetes cases was 8.0% and new diabetes cases was 3.8% during the period.
Reasons to Purchase this Report
• Current and future of Non Invasive Diabetes Therapy Market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations
Christmas Sale Is Live !!!!
Buy Now To Avail Discount From 25-30% Till 31-Dec-2021
Buy This Research Study Report Here @ https://www.coherentmarketinsights.com/insight/buy-now/54
North America is also expected to witness significant growth in the global non-invasive diabetes therapy market, owing to high prevalence of diabetes in the region. For instance, according to International Diabetes Federation’s IDF Diabetes Atlas 2019 Edition, the numbers of adults with diabetes in the U.S. was 31.0 million.
Global Non-Invasive Diabetes Therapy Market: Competition Landscape
Major players operating in the global non-invasive diabetes therapy market include, ACON Laboratories, B. Braun Melsungen, Bayer AG, Bio Tex, Calisto Medical, and DexCom.
Do You Have Specific Requirement? Ask To Our Experts: https://www.coherentmarketinsights.com/insight/talk-to-analyst/54
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027